Sinead – DLBCL published April 27, 2023 I was diagnosed with non hodgkins lymphoma towards the end of January after I went to my GP about a lump in my Read more
Registrations are now open for Legs Out for Lymphoma 2023! 🏃 published December 7, 2022 We are excited to bring you Legs Out for Lymphoma 2023! Join us this March and use your Legs for Good! Sign u Read more
Lymphoma Awareness Month – on now! published September 1, 2022 Lymphoma Awareness Month is here! September Awareness Month September has arrived and it’s time to put l Read more
Lymphoma Newsletter – August 2022 published August 4, 2022 In this months newsletter we share the following updates: Lymphoma Awareness Month – get i Read more
Lymphoma Newsletter – June 2022 published June 28, 2022 In this months newsletter we will be sharing the following updates: Update your details – ge Read more
Lymphoma Newsletter – March 2022 published March 7, 2022 In this month’s newsletter:Legs Out 2022 – join our national event!!Friday 11 March is Legs 1 Read more
ALLG Celebrating 50 Years published April 12, 2023 Media Release: Blood cancer group’s five decades of research for better treatments Read more
World Lymphoma Awareness Day 2022 published September 15, 2022 Putting lymphoma in the limelight Today we join the global lymphoma community to acknowledge and support Worl Read more
September Lymphoma Awareness Month published August 11, 2022 Lymphoma Awareness Month is almost here!Lymphoma is the 6th most common cancer in Australia and the number one Read more
New cancer drug boosts survival in patients with lymphoma published October 11, 2017 Written by Lucie van den Berg, Medical reporter, Herald Sun October 5, 2017 4:02pm A RE-ENGINEERED canc Read more
Drug subsidy gives hope to cancer sufferers published October 11, 2017 $187,000 to $6.30: Turnbull drug subsidy gives hope to cancer sufferersWritten by Adam Gartrell, Health C Read more
Clinical Trials for CLL and Waldenstrom’s published April 19, 2017 Watch Australian Haematologist Con Tam talk about clinical trials investigating BGB-3111 in CLL and Waldenstro Read more